BackFidelity Advisor Biotechnology Fund Class A Overview

Fidelity Advisor Biotechnology Fund Class A Inventory

Latest inventory for FBTAX: $63M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$63.50M
↓ 17.03% YoYΔ $-13.03M vs prior year quarter

Peer trimmed avg / median

Loading

Fidelity Advisor Biotechnology Fund Class A Inventory History

Loading

Fidelity Advisor Biotechnology Fund Class A vs. peers: Inventory Comparison

Loading

Fidelity Advisor Biotechnology Fund Class A Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Fidelity Advisor Biotechnology Fund Class A (FBTAX) FAQ

The latest inventory for FBTAX is $63M as of February 2024. That compares with $77M in the prior-year period — down 17.0% year over year. Investors often review this figure alongside Fidelity Advisor Biotechnology Fund Class A's historical trend and sector peers before judging valuation or financial health.

Over the past year, FBTAX's inventory moved from $77M to $63M — a 17.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fidelity Advisor Biotechnology Fund Class A's operating scale or balance-sheet position.

A inventory figure of $63M for FBTAX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting FBTAX's inventory ($63M), review year-over-year change from $77M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.